|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other (expense) income | |||||
| Loss from operations before income taxes | |||||
| Income tax benefit (expense) | |||||
| Net loss | |||||
| Foreign currency translation adjustments | |||||
| Comprehensive loss | |||||
| Net loss per share: basic | |||||
| Net loss per share: diluted | |||||
| Weighted-average shares outstanding: basic | |||||
| Weighted-average shares outstanding: diluted | |||||
Loading...